%0 Case Reports
%T Chronic Macular Oedema as a Late MIRAgel-Related Complication.
%A Chean CS
%A Lim CS
%A Mudhar HS
%A Lokovitis E
%A Sampath R
%J Vision (Basel)
%V 5
%N 4
%D Nov 2021 8
%M 34842848
暂无%R 10.3390/vision5040055
%X <B>BACKGROUND: </B>MIRAgel® (MIRA, Waltham, MA, USA) is a hydrogel scleral buckle introduced in 1979 to treat rhegmatogenous retinal detachments. Its use was discontinued because late complications that require surgical removal were reported.<BR><B>METHODS: </B>Case report.<BR><B>RESULTS: </B>We report a case of left eye MIRAgel® buckle surgery 28 years ago presenting with a tender palpable erythematous swelling at the lower lid, with marked conjunctival chemosis and progressive ophthalmoplegia. Imaging revealed a large, well-defined, horseshoe-shaped lesion in the extraconal space of the left orbit with globe distortion, with histological confirmation of an expanded hydrogel buckle. He recovered well following removal of the explant but developed chronic macular oedema a year later, which persisted despite sub-Tenon's triamcinolone injections. Repeat imaging demonstrated remaining hydrogel explant. Macular oedema settled well upon successful surgical removal with no recurrence to date.<BR><B>CONCLUSIONS: </B>Our case is the first to describe macular oedema as a late MIRAgel-related complication, with complete removal of the explant being the definitive treatment. Macular oedema indicates postoperative inflammation secondary to the remaining explant fragments. Given the friability of hydrolysed MIRAgel®, we recommend ophthalmologists to warn patients regarding the possibility of further inflammation in the globe or the orbit in case of incomplete removal.